StockData
MBX Biosciences, Inc. logo

MBX Biosciences, Inc. (MBX) stock

MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$53.10−0.02 (-0.04%)

Close on Nov 17, 2026Market cap $2.56BP/E –Yield –

MBX Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

MBX Biosciences's price to book ratio was 6.8× on Nov 11, 2026, against 4.0× a year earlier. Over the last 2 years it ranged from 1.0× to 7.2×, with a median of 3.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.8×+3.1
2025Dec 31, 20253.6×+1.4
2024Dec 31, 20242.3×–

More MBX Biosciences figures

See a number that looks wrong?